Your browser doesn't support javascript.
loading
Therapeutic approaches for chronic hepatitis C: a concise review.
Nawaz, Allah; Manzoor, Azhar; Ahmed, Saeed; Ahmed, Naveed; Abbas, Waseem; Mir, Mushtaq Ahmad; Bilal, Muhammad; Sheikh, Alisha; Ahmad, Saleem; Jeelani, Ishtiaq; Nakagawa, Takashi.
Afiliación
  • Nawaz A; Joslin Diabetes Center, Harvard Medical School, Harvard University, Boston, MA, United States.
  • Manzoor A; Department of Molecular and Medical Pharmacology, Faculty of Medicine, University of Toyama, Toyama, Japan.
  • Ahmed S; Department of Surgery, Bahawal Victoria Hospital, Bahawalpur, Pakistan.
  • Ahmed N; Department of Medicine, and Surgery, Rawalpindi Medical University, Rawalpindi, Punjab, Pakistan.
  • Abbas W; Department of Pharmacy, University of Poonch Rawalakot, Rawalakot, Azad Jammu and Kashmir (AJ&K), Pakistan.
  • Mir MA; Department of Molecular and Medical Pharmacology, Faculty of Medicine, University of Toyama, Toyama, Japan.
  • Bilal M; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia.
  • Sheikh A; First Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama, Japan.
  • Ahmad S; Jammu Institute of Ayurveda and Research, University of Jammu, Jammu, India.
  • Jeelani I; Cardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA, United States.
  • Nakagawa T; Department of Molecular and Medical Pharmacology, Faculty of Medicine, University of Toyama, Toyama, Japan.
Front Pharmacol ; 14: 1334160, 2023.
Article en En | MEDLINE | ID: mdl-38283838
ABSTRACT
Hepatitis C virus (HCV) infection is a significant global health concern, prompting the need for effective treatment strategies. This in-depth review critically assesses the landscape of HCV treatment, drawing parallels between traditional interferon/ribavirin therapy historically pivotal in HCV management and herbal approaches rooted in traditional and complementary medicine. Advancements in therapeutic development and enhanced clinical outcomes axis on a comprehensive understanding of the diverse HCV genome, its natural variations, pathogenesis, and the impact of dietary, social, environmental, and economic factors. A thorough analysis was conducted through reputable sources such as Science Direct, PubMed, Scopus, Web of Science, books, and dissertations. This review primarily focuses on the intricate nature of HCV genomes and explores the potential of botanical drugs in both preventing and treating HCV infections.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos